摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-[(3-{[(t-butoxycarbonyl)amino]methyl}-4-methoxyphenyl)(hydroxy)methyl]tetrahydro-2-furancarboxylate | 499789-31-0

中文名称
——
中文别名
——
英文名称
methyl 2-[(3-{[(t-butoxycarbonyl)amino]methyl}-4-methoxyphenyl)(hydroxy)methyl]tetrahydro-2-furancarboxylate
英文别名
methyl 2-[hydroxy-[4-methoxy-3-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]phenyl]methyl]oxolane-2-carboxylate
methyl 2-[(3-{[(t-butoxycarbonyl)amino]methyl}-4-methoxyphenyl)(hydroxy)methyl]tetrahydro-2-furancarboxylate化学式
CAS
499789-31-0
化学式
C20H29NO7
mdl
——
分子量
395.453
InChiKey
DHSTUDGRTSAQGU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    28
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    103
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • Cyclic compound and ppar agonist
    申请人:Clark Richard
    公开号:US20050014833A1
    公开(公告)日:2005-01-20
    The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R 1 to R 6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A 1 and A 2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula: represents a single bond or a double bond; X represents a single bond, an oxygen atom, —NR X1 CQ 1 O—, etc.; Y represents Y 1 —Y 2 — (wherein Y 1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y 2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.
    本发明提供了一种具有出色PPAR激动剂作用的新化合物。更具体地说,它提供了一种由以下公式表示的化合物,其盐,酯或水合物。其中a,b和c彼此相同或不同,每个表示0到4; R1至R6彼此相同或不同,每个表示氢原子,羟基,氰基,卤素原子等; A1和A2彼此相同或不同,每个表示单键,氧原子等; L,M和T每个表示单键,具有一到六个碳原子的烷基等; W表示羧基;由以下公式表示的部分结构:表示单键或双键; X表示单键,氧原子,-NRX1CQ1O-等; Y表示Y1-Y2-(其中Y1表示具有一到四个取代基的5到14个成员的芳香环等; Y2表示单键或5到14个成员的芳香环); 而环Z表示从上述A族中选择的具有一到四个取代基的5到14个成员的芳香环,可以具有一个或多个杂原子,并且可以部分饱和。
  • Cyclic compound and PPAR agonist
    申请人:Eisai Co., Ltd.
    公开号:US07371777B2
    公开(公告)日:2008-05-13
    The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R1 to R6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A1 and A2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula: represents a single bond or a double bond; X represents a single bond, an oxygen atom, —NRx1CQ1O—, etc.; Y represents Y1—Y2— (wherein Y1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.
    本发明提供了一种具有出色PPAR激动剂作用的新化合物。更具体地说,它提供了一种由以下公式表示的化合物,其盐,酯或其水合物。其中a、b和c相同或不同,分别表示0到4;R1至R6相同或不同,分别表示氢原子,羟基,氰基,卤素原子等;A1和A2相同或不同,分别表示单键,氧原子等;L、M和T各自表示单键,具有1至6个碳原子的烷基等;W表示羧基;由以下公式表示的部分结构:表示单键或双键;X表示单键,氧原子,-NRx1CQ1O-等;Y表示Y1-Y2-(其中Y1表示具有1至4个取代基的5至14环芳烃环等;Y2表示单键或5至14环芳烃环);环Z表示具有1至4个从上述A组中选择的取代基的5至14环芳烃环,可以具有一个或多个杂原子,并且可以部分饱和。
  • CYCLIC COMPOUND AND PPAR AGONIST
    申请人:Eisai Co., Ltd.
    公开号:EP1452521A1
    公开(公告)日:2004-09-01
    The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R1 to R6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A1 and A2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula: ------¯ represents a single bond or a double bond; X represents a single bond, an oxygen atom, -NRX1CQ1O-, etc.; Y represents Y1-Y2- (wherein Y1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.
    本发明提供了一种具有优异 PPAR 激动剂作用的新型化合物。更具体地说,它提供了由下式代表的化合物、其盐、其酯或它们的水合物。 其中 a、b 和 c 彼此相同或不同,各自代表 0 至 4;R1 至 R6 彼此相同或不同,各自代表氢原子、羟基、氰基、卤素原子等; A1 和 A2 彼此相同或不同,各自代表单键、氧原子等; L、M 和 T 各自代表单键、具有 1 至 6 个碳原子的亚烷基等; W 代表羧基; 式所代表的部分结构: ------¯ 代表单键或双键; X 代表单键、氧原子、-NRX1CQ1O- 等; Y 代表 Y1-Y2-(其中 Y1 代表具有 1 至 4 个取代基的 5 至 14 元芳香环等;Y2 代表单键或 5 至 14 元芳香环);以及 环 Z 代表 5 至 14 元芳香环,该环具有 1 至 4 个从上述 A 组中选出的取代基,可具有一个或多个杂原子,并可部分饱和。
  • US7371777B2
    申请人:——
    公开号:US7371777B2
    公开(公告)日:2008-05-13
  • EP1452521
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多